• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连续检测急性缺血性脑卒中患者的血浆核和线粒体 DNA 水平的价值。

The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke.

机构信息

Department of Neurology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan.

出版信息

Clin Chim Acta. 2011 Feb 20;412(5-6):476-9. doi: 10.1016/j.cca.2010.11.036. Epub 2010 Dec 3.

DOI:10.1016/j.cca.2010.11.036
PMID:21130757
Abstract

BACKGROUND

Elevated circulating cell-free DNA in plasma is reported in several critical diseases. This study hypothesized that since plasma nuclear and mitochondrial DNA substantially increase after acute ischemic stroke and decrease thereafter, their levels can predict treatment outcomes.

METHODS

Plasma nuclear and mitochondrial DNA levels were serially examined in 50 acute ischemic stroke patients and in 50 at risk control subjects during the study period.

RESULTS

Levels of plasma nuclear and mitochondrial DNA in patients with acute ischemic stroke were significantly higher than those in the controls (p<0.05). Elevated circulating nuclear DNA in plasma persisted until one month after the acute stroke. Levels of plasma nuclear DNA positively correlated to the clinical severity of stroke as reflected by the National Institutes of Health Stroke Scale.

CONCLUSION

Levels of plasma nuclear and mitochondrial DNA reflect the severity of cerebral damage after acute cerebral infarction. Assay of plasma DNA levels can be considered a neuro-pathologic marker of patients with acute ischemic stroke.

摘要

背景

已有研究报道,在多种危急病症中,血浆中的循环游离 DNA 水平会升高。本研究假设,由于急性缺血性脑卒中后,血浆核 DNA 和线粒体 DNA 含量大幅增加,随后又逐渐降低,因此其水平可以预测治疗效果。

方法

在研究期间,对 50 例急性缺血性脑卒中患者和 50 例高危对照者的血浆核 DNA 和线粒体 DNA 水平进行了连续检测。

结果

急性缺血性脑卒中患者的血浆核 DNA 和线粒体 DNA 水平显著高于对照组(p<0.05)。急性脑卒中后一个月内,血浆中循环核 DNA 的水平仍持续升高。血浆核 DNA 水平与国立卫生研究院卒中量表(NIHSS)所反映的脑卒中严重程度呈正相关。

结论

血浆核 DNA 和线粒体 DNA 水平反映了急性脑梗死后脑损伤的严重程度。检测血浆 DNA 水平可被视为急性缺血性脑卒中患者的神经病理标志物。

相似文献

1
The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke.连续检测急性缺血性脑卒中患者的血浆核和线粒体 DNA 水平的价值。
Clin Chim Acta. 2011 Feb 20;412(5-6):476-9. doi: 10.1016/j.cca.2010.11.036. Epub 2010 Dec 3.
2
The value of serial plasma nuclear and mitochondrial DNA levels in adult community-acquired bacterial meningitis.成人社区获得性细菌性脑膜炎中连续血浆核和线粒体 DNA 水平的价值。
QJM. 2010 Mar;103(3):169-75. doi: 10.1093/qjmed/hcp201. Epub 2010 Feb 2.
3
Homocysteine and lipoprotein (a) correlation in ischemic stroke patients.缺血性中风患者中同型半胱氨酸与脂蛋白(a)的相关性
J Neurol Sci. 2009 Jun 15;281(1-2):64-8. doi: 10.1016/j.jns.2009.02.341. Epub 2009 Mar 13.
4
Elevated visfatin/pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke.缺血性卒中患者血浆内脂素/前B细胞集落增强因子浓度升高。
J Stroke Cerebrovasc Dis. 2009 Sep-Oct;18(5):354-9. doi: 10.1016/j.jstrokecerebrovasdis.2009.01.003.
5
Plasma biomarkers in the diagnosis of acute ischemic stroke.血浆生物标志物在急性缺血性卒中诊断中的应用
Ann Clin Lab Sci. 2010 Fall;40(4):336-41.
6
Homocysteine--risk factor for ischemic stroke?同型半胱氨酸——缺血性中风的风险因素?
Indian J Physiol Pharmacol. 2009 Jan-Mar;53(1):34-8.
7
Expression of IL-6 activity in patients with acute ischemic stroke.急性缺血性脑卒中患者白细胞介素-6活性的表达
Rom J Intern Med. 2009;47(4):393-6.
8
Natural history of blood glucose within the first 48 hours after ischemic stroke.缺血性卒中后48小时内血糖的自然病程。
Neurology. 2008 Mar 25;70(13):1036-41. doi: 10.1212/01.wnl.0000306635.08410.68.
9
Plasma homocysteine and ischemic stroke patients in Thailand.泰国血浆同型半胱氨酸与缺血性中风患者
J Med Assoc Thai. 2007 Jun;90(6):1183-7.
10
Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.良性和恶性卵巢肿瘤中循环游离核DNA和线粒体DNA的水平。
Obstet Gynecol. 2008 Oct;112(4):843-50. doi: 10.1097/AOG.0b013e3181867bc0.

引用本文的文献

1
Circulating cfdna: A novel biomarker for preventing early recurrence in ischemic stroke.循环游离DNA:一种预防缺血性中风早期复发的新型生物标志物。
J Thromb Thrombolysis. 2025 Sep 16. doi: 10.1007/s11239-025-03179-y.
2
Relationship between first pass effect NLR and PLR in mechanical thrombectomy for acute anterior circulation large-vessel occlusion.急性前循环大血管闭塞机械取栓术中首过效应中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)的关系
Front Neurol. 2025 Jul 2;16:1490127. doi: 10.3389/fneur.2025.1490127. eCollection 2025.
3
Intra-Arterial Deoxyribonuclease Therapy Improves Stroke Outcomes in Aged Mice.
动脉内脱氧核糖核酸酶治疗可改善老年小鼠的中风预后。
CNS Neurosci Ther. 2025 Jun;31(6):e70461. doi: 10.1111/cns.70461.
4
Cell-Free Nucleic Acids for Early Diagnosis of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.用于急性缺血性卒中早期诊断的游离核酸:系统评价与荟萃分析
Int J Mol Sci. 2025 Feb 12;26(4):1530. doi: 10.3390/ijms26041530.
5
The mitochondria as a potential therapeutic target in cerebral I/R injury.线粒体作为脑缺血/再灌注损伤的潜在治疗靶点。
Front Neurosci. 2025 Jan 7;18:1500647. doi: 10.3389/fnins.2024.1500647. eCollection 2024.
6
Markers of Mitochondrial Injury and Neurological Outcomes of Comatose Patients after Cardiac Arrest.心脏骤停后昏迷患者的线粒体损伤标志物与神经功能结局。
Medicina (Kaunas). 2024 Aug 9;60(8):1286. doi: 10.3390/medicina60081286.
7
The Circulating Biomarkers League: Combining miRNAs with Cell-Free DNAs and Proteins.循环生物标志物联盟:将 microRNAs 与游离 DNA 和蛋白质相结合。
Int J Mol Sci. 2024 Mar 17;25(6):3403. doi: 10.3390/ijms25063403.
8
Mitochondrial DNA levels in perfusate and bile during normothermic machine correspond with donor liver quality.常温机器灌注期间灌注液和胆汁中的线粒体DNA水平与供肝质量相关。
Heliyon. 2024 Feb 24;10(5):e27122. doi: 10.1016/j.heliyon.2024.e27122. eCollection 2024 Mar 15.
9
Immunothrombosis in neurovascular disease.神经血管疾病中的免疫血栓形成
Res Pract Thromb Haemost. 2023 Dec 20;8(1):102298. doi: 10.1016/j.rpth.2023.102298. eCollection 2024 Jan.
10
Plasma biomarkers for brain injury in extracorporeal membrane oxygenation.体外膜肺氧合中脑损伤的血浆生物标志物
Acute Crit Care. 2023 Nov;38(4):389-398. doi: 10.4266/acc.2023.01368. Epub 2023 Nov 29.